About Telor Pharmaceuticals
Producer of ophthalmic pharmaceuticals to treat chronic eye diseases. The company completed a $20mm IPO and later merged with Occupational Health and Rehabilitation, Corp.
Missing: Telor Pharmaceuticals's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Telor Pharmaceuticals's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Telor Pharmaceuticals Frequently Asked Questions (FAQ)
Where is Telor Pharmaceuticals's headquarters?
Telor Pharmaceuticals's headquarters is located at 265 Ballardvale Street, Wilmington.
What is Telor Pharmaceuticals's latest funding round?
Telor Pharmaceuticals's latest funding round is Other Investors.
Who are the investors of Telor Pharmaceuticals?
Investors of Telor Pharmaceuticals include Alloy Ventures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.